Top Midday Gainers

MT newswire2026/10/08 18:30

02:30 PM EDT, 10/08/2026 (MT Newswires) -- Viatris (VTRS) agreed to acquire Pacira BioSciences (PCRX) in an all-cash deal worth roughly $1.65 billion to strengthen its non-opioid pain management portfolio, according to a statement released Thursday. Pacira shares soared 44%, with intraday trading volume catapulting to more than 24.4 million from a daily average of about 589,000. Haemonetics (HAE) said in a filing Thursday that CSL Plasma expects to complete the rollout of Haemonetics' devices and disposables by the end of 2027. Shares climbed 16% as intraday trading volume rose to over 1.90 million, versus a daily average of roughly 679,000. UBS adjusted its price target on XP (XP) to $37 from $25 while keeping its buy rating for the stock. XP shares jumped 4% as intraday trading volume rose to over 8.59 million from a daily average of about 6.87 million. Price: 17.35, Change: -0.14, Percent Change: -0.80

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

BUZZ - Pharmaceutical company Liquidia surges after reaching a settlement with United Therapeutics

路透社•2026/10/14 08:51

Can a $20 monthly Siri subscription turn Apple (AAPL.US) into a "money-printing machine"? Analyst: It may generate 24 billions in annual revenue, with smart home contributing less than 1%.

Gene Munster, managing partner at Deepwater Asset Management, stated that Apple’s (AAPL.US) newly launched smart home product is expected to contribute slightly less than 1% to revenue in fiscal year 2027.

智通财经•2026/10/14 08:43

ASML CFO says the US 'March Act' restrictions on selling deep ultraviolet lithography machines to China will be counterproductive

路透社•2026/10/14 08:36

Liberty Global Says VodafoneZiggo Tower Sale Cleared by EU Commission

MT newswire•2026/10/14 08:23